Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code M32.15

Tubulo-interstitial nephropathy in systemic lupus erythematosus.

Coding should accurately reflect the clinical documentation.Ensure that the diagnosis of SLE is well-established before assigning the code M32.15.The severity of the kidney involvement should be documented to guide appropriate coding and reimbursement.

Modifiers may be applicable depending on the circumstances of the visit and the services provided. Consult your local payer guidelines for specific modifier requirements.

Medical necessity for coding M32.15 is established by the presence of clinical findings consistent with tubulo-interstitial nephropathy in a patient with a documented diagnosis of SLE. The severity of the kidney involvement, as indicated by laboratory tests and imaging studies, will determine the intensity and type of treatment.

Diagnosis and management of tubulo-interstitial nephropathy in SLE requires a multidisciplinary approach involving rheumatologists, nephrologists, and other specialists.The clinical responsibility includes obtaining a thorough patient history, performing a physical examination, ordering appropriate laboratory tests (blood tests, urinalysis), imaging studies (ultrasound), and possibly a kidney biopsy.Treatment involves prescribing and managing immunosuppressive and anti-inflammatory medications, monitoring kidney function, and educating the patient about the disease and its management.

IMPORTANT:ICD-9 codes 583.81 (Nephritis and nephropathy not specified as acute or chronic in diseases classified elsewhere) and 710.0 (Systemic lupus erythematosus) may be considered as related codes, depending on the context and clinical documentation.

In simple words: This code describes kidney damage caused by lupus, an autoimmune disease where the body attacks its own tissues.The kidney inflammation can lead to swelling, fatigue, and changes in urination. Doctors diagnose it through tests and may treat it with medications to suppress the immune system and reduce inflammation.

Tubulo-interstitial nephropathy is a kidney disorder characterized by inflammation of the kidney tubules and the spaces between them. It occurs as a complication of systemic lupus erythematosus (SLE), an autoimmune disease affecting multiple organs, including the skin, heart, lungs, kidneys, and nervous system.Symptoms may include hematuria (blood in the urine), edema (swelling), malaise (general ill feeling), altered urine output, unexplained fever, fatigue, and skin rashes. Diagnosis is based on patient history, physical examination, imaging (such as ultrasound), blood tests (creatinine, urea nitrogen), urinalysis, and kidney biopsy. Treatment typically involves immunosuppressants like cyclophosphamide and corticosteroids such as prednisolone to reduce inflammation.

Example 1: A 35-year-old female patient with a known history of SLE presents with edema, fatigue, and changes in urine output.Laboratory tests reveal elevated creatinine and urea nitrogen levels, along with hematuria. A kidney biopsy confirms the diagnosis of tubulo-interstitial nephropathy., A 40-year-old male patient with SLE is experiencing worsening fatigue and decreased urine output. Urinalysis shows proteinuria and microscopic hematuria.Further investigation with blood tests and imaging confirms the presence of tubulo-interstitial nephropathy., A 28-year-old female patient, newly diagnosed with SLE, presents with subtle symptoms such as mild proteinuria and fatigue.Prophylactic treatment with immunosuppressants is initiated to prevent the development of tubulo-interstitial nephropathy.

* Detailed patient history including symptoms, duration, and SLE diagnosis.* Physical examination findings, specifically noting edema and any other relevant findings.* Results of laboratory tests including complete blood count (CBC), creatinine, BUN, urinalysis, and any relevant serological markers for SLE.* Imaging studies, such as ultrasound, to assess kidney size and structure.* Kidney biopsy report if performed.* Treatment plan including medication details and response to treatment.

** This code is highly specific and requires robust clinical documentation to support its use.Any conflicting information in the patient's medical record should be clarified with the treating physician before coding.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.